Medifast
Price
Prix
Dividendes historiques et prévisions
Le prochain dividende sera payé le 07.02.2025
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Medifast ?
Quel est le ratio cours/bénéfice (P/E) de Medifast ?
Quel est le bénéfice par action (BPA) de Medifast ?
Quelles sont les évaluations des analystes et le prix cible de l'action Medifast ?
Quel est le chiffre d'affaires de Medifast sur les douze derniers mois ?
Quel est l'EBITDA de Medifast ?
Quel est le flux de trésorerie disponible de Medifast ?
Quel est le bêta à 5 ans de l'action Medifast ?
Combien d'employés compte Medifast, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Medifast ?
Finances
Capitalisation boursière
200,16 M $USbêta sur 5 ans
1,18BPA (TTM)
0,669 $USFree Float
10,66 MRatio P/E (TTM)
27,33Recettes (TTM)
674,48 M $USEBITDA (TTM)
23,72 M $USCash-flow disponible (TTM)
15,14 M $USCotation
Notes des analystes
L'objectif de prix est de 21,25 $US et l'action est analysée par 2 analystes.
Acheter
0
Hold
1
Vendre
1
Informations
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
634
Biotechnology & Drugs
Biens de consommation de base
Identifiant
ISIN
Ticker primaire